Skip to main content

GTS SECURITIES LLC

Broker-Dealer

Position in ABBV — AbbVie Inc.

CIK 1452765 NEW YORK, NY

Position in ABBV

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$899,361
-$491,052 QoQ
Shares Held
3,574
-44.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#2,646
of 4,153 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ABBV Over Time

Shares Held

Position Value (USD)

Derivatives in ABBV

reported options exposure · as of Sep 30, 2024
CallValue
$42,260,720
CallShares
214,000
PutValue
$23,243,396
PutShares
117,700

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

GTS SECURITIES LLC holds $12,976,736 across 10 Drug Manufacturers - General names. ABBV ranks #5 (6.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 ABBV
AbbVie Inc.
This page
3,574 $899,361

All Filings in ABBV

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $899,361 3,574
2026-03-31 $1,390,413 6,393
2025-12-31 $4,284,187 18,750
2025-09-30 $1,879,873 8,119
2025-06-30 $1,994,858 10,747
2025-03-31 $4,303,331 20,539
2024-12-31 $1,495,345 8,415
2024-09-30 $4,605,628 23,322
2024-09-30 $42,260,720 214,000
2024-09-30 $23,243,396 117,700
2024-06-30 $18,935,808 110,400
2024-06-30 $1,574,382 9,179
2024-06-30 $31,508,224 183,700
2024-03-31 $14,240,220 78,200
2024-03-31 $485,114 2,664
2024-03-31 $30,592,800 168,000
2023-12-31 $15,481,503 99,900
2023-12-31 $14,726,489 95,028
2023-12-31 $42,384,295 273,500
2023-09-30 $2,015,589 13,522
2023-09-30 $21,434,828 143,800
2023-09-30 $38,830,130 260,500